MedTrace Logo

Phase Contrast in Valvular Heart Disease

NCT03669666 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2018-09-13

No results posted yet for this study

Summary

The ability to quantify flow directly using through-plane phase contrast velocity mapping is a unique advantage of cardiovascular magnetic resonance and does not rely on the calculation from complex equations as echocardiography.

The aim s is to study the role of cardiac MRI in the evaluation of valvular heart disease through quantification of the impact of valvular lesions upon cardiac function by accurate estimation of the left ventricular ejection fraction

Conditions

  • Valvular Heart Disease (Aortic and Mitral Valves)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-06-30
Completion
2018-07-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03669666 on ClinicalTrials.gov